Shoulder

Rotation Medical, Inc. tells us it has received U.S. FDA 510(k) clearance for its implantable collagen scaffold technology. The new technology is designed for use during arthroscopic and mini-open procedures to help support clinical management and protection of tendon injuries in which there has been no substantial loss of tendon tissue.

Exactech, Inc. has taken the opportunity presented by this week’s AAOS meeting to announce successful first surgeries using its new Equinoxe® Resurfacing Humeral Head.

Whether this is a milestone or not remains to be seen, but it just might be. The PEEK polymer has become a household name in orthopaedic implants and now MedShape is offering devices with the combined advantages of PEEK and a porous structure to encourage tissue ingrowth.

Putting a few troubled years behind it, US Sports med, Spine and ENT device maker ArthroCare has been acquired by Smith and Nephew in a deal that values the Austin, Texas outfit at $1.7 Billion.

Musculoskeletal device specialist DJO Global, Inc., tells us its Match Point System™ patient-specific shoulder instrumentation has seen its first use in Reverse® Shoulder System cases in Australia Florida.

Orthopaedic device giant Biomet, Inc., has trumpeted the first U.S. implantation of its Comprehensive® Nano Stemless Shoulder. The procedure was part of an FDA Investigational Device Exemption (IDE) multi-center prospective clinical study.

Integra LifeSciences Holdings Corporation has announced the first implantation of its Integra® Titan™ Reverse Shoulder System, in the United States. The system offers surgeons minimally invasive intraoperative options, and the ability to offer continued care for the lifetime of their patient.

Zimmer’s PSI Shoulder utilizes 3D visualization software to allow a surgeon to create a customized surgical plan for each patient, and then provides patient-specific surgical instrument guides to facilitate placement of the implant corresponding to the plan.

Integra LifeSciences Holdings Corporation has announced that the Integra® Titan™ Reverse Shoulder System has received 510k clearance from the U.S. FDA. … continue reading “FDA Clears Integra’s Titan™ Reverse Shoulder System”

Ceterix™ Orthopaedics, Inc. has announced the commercial availability of its NovoStitch™ suture passer in the United States. The device enables surgeons to place stitches in tight joint compartments, including those in knees, hips and shoulders, during minimally invasive arthroscopic surgical procedures.

It’s sports med week this week, with the annual gathering that is the AOSSM meeting taking place in Chicago. Mitek Sports Medicine, a DePuy Synthes Company, under the wing of Johnson & Johnson, has used the event to showcase its new HEALIX ADVANCE™ KNOTLESS Anchor, a new suture anchor it says is designed to provide optimal knotless fixation for rotator cuff repair.

Parametrics Medical, LLC, a private tissue bank has announced its release of its Coll-e-Strong line of soft tissue allografts. Using E-Beam Technology, to terminally sterilize the tissue without compromising the biomechanical properties of the collagen, the company claims its allograft line is the first to bridge the gap between biomechanics and sterility.

Mitek Sports Medicine has unveiled the Healix 3.4mm Suture Anchor, its smallest dual-thread offering for rotator cuff repair. This coincides with the introduction of a new double-loaded minimally invasive partial thickness rotator cuff repair system, as part of its Healix Transtend™ Implant System.

US shoulder device company Shoulder Options Inc., is launching its AFT™ Proximal Humerus Fracture Plate. The new plate is intended for the treatment of fractures and fracture dislocations, osteotomies, and non-unions of the proximal humerus.

Steven Ek has been named ArthroSurface’s President and Chief Executive Officer, effective November 20, 2012. Mr. Ek is one of the original founders in Arthrosurface and a Director since inception.

Biomet has released its financial results for the most recent quarter, showing a net sales increase of 9% compared with a year ago. Income and earnings showed similarly healthy increases, although one-off costs translated into a significantly bigger net loss than in the equivalent period.